Focus areas
Focus areas on OpenBioDx: cross-cutting diagnostics themes, from precision medicine and mass spectrometry to maternal and newborn health, the global south and WHO guidance.
Precision Medicine125
Genomically guided, individualised diagnostics that match the right test and therapy to the right patient.
- Saliva liquid biopsy captures multi-omic disease signals across oral and systemi
- Single-cell CTC profiling captures PI3K/AKT/PTEN alterations missed by ctDNA in
- CRISPR RNA engineering strategies enhance single-nucleotide discrimination in nu
Mass Spectrometry163
LC-MS/MS and clinical mass spectrometry across the diagnostic laboratory, from proteomics to therapeutic monitoring.
- Saliva liquid biopsy captures multi-omic disease signals across oral and systemi
- Whole-genome sequencing tracks ST80 dissemination and combined vancomycin-linezo
- Amniotic fluid proteomic panel stratifies persistent versus transient fetal grow
Maternal & Newborn72
Prenatal, perinatal and newborn-screening diagnostics, including dried-blood-spot programmes and non-invasive prenatal testing.
- Dried blood spot screening for congenital hypothyroidism supports newborn screen
- Interval-specific likelihood ratios refine antiphospholipid antibody interpretat
- Prenatal exome sequencing could have diagnosed one-fifth of monogenic cases miss
Aldosterone & Adrenal11
Aldosterone, renin and adrenal testing, from primary aldosteronism to congenital adrenal hyperplasia screening.
- ID-LC-MS/MS candidate reference procedure standardizes serum DHEAS quantificatio
- CDC and PCOS Challenge outline work plan for standardized female and pediatric t
- Lorundrostat, a Novel Aldosterone Synthase Inhibitor, Significantly Lowers Blood
Global South72
Diagnostics for the developing world and resource-limited settings, where access, decentralisation and cost decide impact.
- Adapting trauma guidelines and point-of-care diagnostics improves LMIC polytraum
- Integrated rapid diagnostics and AI prediction accelerate targeted antibiotic th
- Decentralized POC HCV testing achieves over 90% uptake in LMICs
WHO Guidelines22
World Health Organization guidance, the Essential Diagnostics List and Emergency Use Listings shaping diagnostics globally.
- Adapting trauma guidelines and point-of-care diagnostics improves LMIC polytraum
- CRISPR-Based Point-of-Care Tests Push Toward Practical H. pylori Screening
- Three Key Practice Updates in Non-Hodgkin Lymphoma Classification for 2026